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Abstract
The formation of a long-lasting memory requires a transcription-dependent consolidation period that
converts a short-term memory into a long-term memory. Nuclear receptors compose a class of transcription
factors that regulate diverse biological processes, and several nuclear receptors have been implicated in
memory formation. Here, we examined the potential contribution of nuclear receptors to memory
consolidation by measuring the expression of all 49 murine nuclear receptors after learning. We identified 13
nuclear receptors with increased expression after learning, including all 3 members of the Nr4a subfamily.
These CREB-regulated Nr4a genes encode ligand-independent “orphan” nuclear receptors. We found that
blocking NR4A activity in memory-supporting brain regions impaired long-term memory but did not impact
short-term memory in mice. Further, expression of Nr4a genes increased following the memory-enhancing
effects of histone deacetylase (HDAC) inhibitors. Blocking NR4A signaling interfered with the ability of
HDAC inhibitors to enhance memory. These results demonstrate that the Nr4a gene family contributes to
memory formation and is a promising target for improving cognitive function.
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deacetylase inhibitors
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The formation of a long-lasting memory requires a transcription-dependent consolidation period that con-
verts a short-term memory into a long-term memory. Nuclear receptors compose a class of transcription fac-
tors that regulate diverse biological processes, and several nuclear receptors have been implicated in memory 
formation. Here, we examined the potential contribution of nuclear receptors to memory consolidation by 
measuring the expression of all 49 murine nuclear receptors after learning. We identified 13 nuclear receptors 
with increased expression after learning, including all 3 members of the Nr4a subfamily. These CREB-regulat-
ed Nr4a genes encode ligand-independent “orphan” nuclear receptors. We found that blocking NR4A activity 
in memory-supporting brain regions impaired long-term memory but did not impact short-term memory in 
mice. Further, expression of Nr4a genes increased following the memory-enhancing effects of histone deacety-
lase (HDAC) inhibitors. Blocking NR4A signaling interfered with the ability of HDAC inhibitors to enhance 
memory. These results demonstrate that the Nr4a gene family contributes to memory formation and is a prom-
ising target for improving cognitive function.
Introduction
Memories are initially stored in a fragile form that can be dis-
rupted by new information, but in the hours following learning 
a transcription-dependent process known as memory consolida-
tion converts these short-term memories into stable long-term 
memories. The cellular mechanisms governing memory consoli-
dation have been the subject of intense study over the past 30 
years. The molecular underpinnings of memory consolidation 
have been most thoroughly studied in a region of the brain known 
as the hippocampus during spatial and contextual memory for-
mation (1). Hippocampus-dependent memory formation requires 
2 waves of protein synthesis (2), cAMP-dependent kinase (PKA) 
activity (2), and de novo transcription in the hippocampus (3) in 
the hours following learning.
Nuclear receptors (NRs) compose the largest class of transcrip-
tion factors found in metazoans (4). Generally, NRs are regulated 
by lipophilic ligands, allowing rapid, ligand-dependent control 
of various developmental and metabolic processes. This fam-
ily includes receptors for fat-soluble vitamins, endocrine hor-
mones, thyroid hormones, fatty acids, bile acids, oxysterols, and 
dietary xenobiotic lipids. Additionally, “orphan” NRs either have 
no ligand or a ligand that has yet to be identified. Several NRs 
have been implicated in the formation of memory. For instance, 
agonists for glucocorticoid receptors, estrogen receptors (ERs), 
PPARs, and retinoic acid receptors (RARs) can improve long-term 
memory formation under certain conditions (5–8). Additionally, 
mice with mutations in the Erb (9), Rarb (10), or the orphan NR 
Nr4a2 have deficits in long-term memory (11).
Despite the importance of NRs to diverse physiological process-
es and data supporting a role of select NRs in memory formation, 
a systematic analysis of NR expression after learning has not been 
previously performed. Therefore, we surveyed the expression of all 
49 NR genes after learning in the single-trial contextual fear-con-
ditioning task. This training protocol produces a robust memory 
that requires the hippocampus, a site of increased gene expres-
sion after learning (12). We examined time points spanning the 
entire 24-hour period after learning and found that 13 NRs have 
increased hippocampal expression in the first 2 hours after train-
ing. Among these 13 learning-induced NRs were all 3 members of 
the Nr4a orphan NR family.
Interestingly, Nr4a family gene expression is activated by many 
of the same signaling cascades that are required for long-term 
memory formation, including cAMP, PKA, and cAMP-response 
element–binding protein (CREB) (reviewed in ref. 1). Further, 
a class of drugs that improves long-term memory formation 
through inhibition of histone deacetylases (HDACs) increases 
the expression of Nr4a genes (13). Therefore, we used a domi-
nant-negative strategy to ascertain whether NR4A signaling con-
tributes to long-term memory formation and the enhancement 
in memory caused by HDAC inhibitors. We found that transgen-
ic expression of a dominant-negative form of NR4A in forebrain 
neurons impairs long-term contextual memory consolidation 
and blocks memory enhancement by intrahippocampal infu-
sion of HDAC inhibitors after training. Further, we identify Bdnf 
and Fosl2 as targets of NR4A signaling that are also enhanced 
by HDAC inhibitor treatment. These results demonstrate a role 
for NR4A signaling in long-term memory formation and the 
enhancement in memory by HDAC inhibitors.
Results
NR gene expression in the hippocampus is regulated by contextual learning. 
To address whether NR gene expression might be associated with 
memory consolidation, we examined hippocampal gene expres-
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sion after contextual fear conditioning, a form of hippocampus-
dependent memory (14). We chose this task because the anatomi-
cal circuitry and molecular signaling cascades underlying this 
form of memory are well established. Additionally, the timings of 
these molecular signaling events are directly measurable relative 
to a single training episode. Contextual fear conditioning is asso-
ciated with 2 waves of CREB phosphorylation after training (15), 
and long-term contextual fear memory is sensitive to inhibitors of 
translation or PKA during 2 time windows that coincide with these 
2 peaks of CREB phosphorylation (2). The first of these windows 
occurs within the first hour after learning, and the second occurs 
between the third and sixth hour after learning (2, 15). Newly 
expressed genes, such as Bdnf, appear to contribute to memory for-
mation even as late as 12 hours after acquisition of fear memories 
(16). For these reasons, we analyzed gene expression in the hip-
pocampus at multiple time points after learning (0.5, 1, 2, 4, 6, 8, 
12, and 24 hours) in comparison to circadian controls (Figure 1A).
Out of the 49 NRs, 13 were not expressed at appreciable levels in 
the hippocampus (Supplemental Figure 1A; supplemental mate-
rial available online with this article; doi:10.1172/JCI64145DS1). 
These 13 genes cluster into the steroidogenesis and bile acid and 
xenobiotic metabolism functional categories (Figure 1C) identi-
fied previously by anatomical profiling of NRs (17). Of those genes 
expressed in the hippocampus, very few showed any evidence of 
altered gene expression in the late time points, more than 2 hours 
after learning (Supplemental Figure 1B). For this reason, we have 
focused on changes in the first 2 hours after training (Figure 1C).
Another 13 NRs showed increased expression in the first 2 hours 
after training (Figure 1B, red in Figure 1C) These 13 genes encode 
6 orphan NRs (Tlx, also known as Nr2e1; NGFI-B, also known as 
Nr4a1; Nurr1, also known as Nr4a2; Nor1, also known as Nr4a3; 
Erra, also known as Nr3b1; Errb, also known as Nr3b2) and 7 recep-
tors with known ligands (Lxra, also known as Nr1h3; LXRB, also 
known as Nr1h2; Ppard, also known as Nr1c2; Pparg, also known as 
Nr1c3; Rara, also known as Nr1b1; Rxra, also known as Nr2b1; Rxrg, 
also known as Nr2b3). Another 23 of the NRs were expressed in the 
hippocampus, but mRNA levels of these genes were not altered in 
the 2-hour window after training (blue in Figure 1C).
NR4A subfamily gene expression is regulated by contextual learning. 
NRs can be grouped into 6 functionally — and evolutionarily — 
related subfamilies (NR1–NR6) and another “catch-all” subfamily 
(NR0) (18). Four of these seven subfamilies are represented with 
the group of training-induced genes found and shown in Figure 1, 
B and C; however, only the NR4 subfamily shows evidence for 
the entire family being induced by learning. The Nr4 gene fam-
ily encodes 3 NR4A NRs: NR4A1 (also known NGFI-B, NUR77, 
and TR3), NR4A2 (also known as NURR1, HZF-3, and RNR1), 
and NR4A3 (also known as NOR1, MINOR, and TEC). Consistent 
with our results, in situ analysis has previously shown that Nr4a1 
expression increases in hippocampal area CA1 (19) and that Nr4a2 
expression increases in hippocampal areas CA1 and CA3 (20) fol-
lowing hippocampus-dependent learning. Additionally, Nr4a2 
heterozygous null mice have impaired hippocampus-dependent 
passive avoidance memory (11), and Nr4a2 knockdown using 
antisense oligodeoxynucleotide injection into the hippocam-
pus impairs long-term memory in a spatial discrimination task 
(21). Further, improved long-term spatial memory performance 
observed by deletion of HDAC3 in the hippocampus is attenuated 
by treatment with siRNA targeting Nr4a2 (22). Therefore, we chose 
to pursue the Nr4a gene family for follow-up studies by first con-
firming that expression of each of the 3 Nr4a genes increases after 
fear conditioning using low-throughput qPCR methods. Con-
textual fear conditioning had a significant overall effect on gene 
expression for each of the 3 Nr4a genes (Nr4a1, P < 0.001, Figure 1D; 
Nr4a2, P = 0.033 Figure 1E; Nr4a3, P = 0.004, Figure 1F). We found 
that Nr4a1 expression increases substantially at 30 minutes after 
contextual fear conditioning (P = 0.009), with transcript levels 
remaining elevated at 60 minutes after training (P = 0.009) but 
returning to baseline by 120 minutes after training. A similar pat-
tern of expression was observed for Nr4a3 (30 minutes, P = 0.028; 
60 minutes, P = 0.016). Nr4a2 expression was significantly elevated 
at 30 minutes after training (P = 0.009). Thus, Nr4a family gene 
expression increases within the hippocampus after training in a 
hippocampus-dependent task.
Generation of a NR4A dominant-negative transgenic mouse line. Our 
data demonstrate that learning induces de novo gene expression 
for all 3 Nr4a family genes during a window in which new gene 
synthesis is required for long-term memory formation (1). Because 
NR4A proteins are ligand-independent NRs (23), the level of gene 
expression is a major factor determining NR4A activity. In the 
hippocampus, Nr4a1 and Nr4a2 are 2 out of only 19 immediate 
early genes for which induction was blocked in CREB conditional 
mutant mice after seizure activity (24). Thus, Nr4a expression may 
be an important part of a CREB-initiated cascade of gene expres-
sion that contributes to the formation of long-term memory. This 
hypothesis is supported by existing data suggesting a role for 
Nr4a2 in long-term memory formation (11, 21). In other biological 
contexts, Nr4a family members have been observed to have redun-
dant functions (25, 26). In these situations, a truncated version 
of NR4A1 that acts as a dominant-negative protein to silence all 
3 family members has been an invaluable tool in deciphering the 
physiological roles of NR4A signaling (25, 27). Further, the involve-
ment of NR4A signaling in distinct processes in different cell types 
(28, 29) and in different anatomical regions (29) calls for a cell-type 
and regionally restricted approach to examine the role of NR4A 
signaling in memory formation. For these reasons, we adapted the 
NR4A dominant-negative approach to allow us to block NR4A sig-
naling in hippocampal neurons. The dominant-negative form of 
Figure 1
The formation of contextual fear memories induces expression of NR 
genes in the hippocampus. (A) Contextual fear conditioning produces 
a long-lasting memory for the training context and the association of 
this context with a mild foot-shock. RNA was collected from whole hip-
pocampi at multiple time points after training to survey the impact of 
training on NR gene expression using a standard ΔΔCT approach. (B) 
High-throughput qPCR data are illustrated for the 13 NR genes with sta-
tistically significant changes in gene expression during the first 2 hours 
after training, the window in which the majority of changes were 
observed. (C) The data from this screen indicate that 13 NRs have 
increased expression in the hippocampus within the first 2 hours after 
training (red), whereas 13 NRs are not appreciably expressed in the 
hippocampus (black). The remaining 23 NRs (blue) show no evidence 
of altered hippocampal expression in the first 2 hours after training. 
Expression changes are illustrated within clusters defined by anatomi-
cal expression profiling (IA, IB, IC, IIA, IIB, IIC) in a diagram modi-
fied with permission from Cell; ref. 17. (D) Nr4a1 expression is potently 
induced in the first hour after learning (P < 0.001). (E) Nr4a2 expres-
sion increases after fear conditioning (P = 0.033). (F) Nr4a3 expression 
increases after fear conditioning (P = 0.004). HC, home cage. Error 
bars represent SEM. *P < 0.05. See also Supplemental Figure 1.
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NR4A1 (NR4ADN) contains the DNA-binding and dimerization 
domains but lacks the transactivation domain (Supplemental Fig-
ure 2A), allowing it to form nonproductive dimers with all 3 NR4A 
proteins (25). As previously reported (25, 27), this truncated form 
of NR4A1 efficiently blocks NR4A-mediated transcriptional activ-
ity (Supplemental Figure 2B). We generated a transgenic mouse 
line expressing the NR4ADN construct under control of the tetra-
cycline operator (tetO), which we combined with the CaMKII–tet-
racycline transactivator (CaMKII-tTA) transgene to achieve expres-
sion selectively within postnatal excitatory forebrain neurons 
(ref. 30 and Figure 2A). Endogenous NR4A2 protein was immu-
noprecipitated from hippocampal extracts with antibodies for 
the yellow fluorescent protein (YFP) tag of the NR4ADN protein 
(Figure 2B), showing that the dominant-negative protein interacts 
with NR4A proteins in vivo. Transgene expression was restricted in 
the forebrain to the striatum, sparse cortical areas, and subregions 
of the hippocampal formation (CA1 and the dentate gyrus) (Fig-
ure 2C). Transgene expression was not observed in the amygdala 
or in area CA3 of the hippocampus (Figure 2C).
NR4A dominant-negative transgenic mice display impaired long-term 
hippocampus-dependent memory. To investigate the role of NR4A 
signaling in memory formation, we examined associative memory 
in NR4ADN mice using the fear-conditioning paradigm (Figure 
2D). As discussed previously, the contextual version of this task 
requires hippocampal function. In contrast, long-term associative 
memory performance for a cue-induced fear response requires the 
Figure 2
Blocking function of NR4A family NRs in the hippocampus impairs long-term memory formation. (A) To impede NR4A signaling in forebrain 
neurons, a tTA transgene expressed selectively in the forebrain was used to activate a dominant-negative Nr4a transgene (NR4ADN) under 
control of the tetO. (B) An antibody to the YFP tag on the transgenic NR4ADN protein coimmunoprecipitates endogenous NR4A2 protein from 
hippocampal protein extracts, confirming the ability of the dominant-negative transgenic protein to heterodimerize with NR4A protein. (C) In the 
top row, immunolabeling for the NR4ADN hemagglutinin (HA) tag (brown) with cresyl violet counterstain (purple) shows expression in the hippo-
campus as well as in cortex and striatum (original magnification, ×100). Fluorescent immunolabeling for the YFP tag (middle row) and propidium 
iodide counterstaining (bottom row) illustrates transgene expression in hippocampal subregions CA1 (original magnification, ×250) and the den-
tate gyrus (DG) (original magnification, ×250) but not the amygdala (original magnification, ×62.5). (D) NR4ADN mice have selective deficits in 
long-term contextual fear memory, whereas neither short-term contextual nor long-term cued fear conditioning are impaired. (E) No difference in 
24-hour contextual fear memory performance was detected between wild-type and NR4ADN mice after 4 weeks of doxycycline (dox) treatment 
(P = 0.87, n = 12 mice/group). All error bars denote SEM. *P < 0.05. See also Supplemental Figure 2.
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same behavioral output, freezing, without requiring hippocampal 
function (14). NR4ADN mice had reduced freezing in a 24-hour 
test of long-term contextual memory (P = 0.03). In contrast, 
cued fear memory was unaffected in NR4ADN mice (P = 0.81), 
suggesting that the deficit in long-term contextual memory per-
formance is likely due to defects in hippocampal function. Long-
term memory deficits could result from either impaired learning 
or impaired memory consolidation, but performance in short-
term memory tests requires learning without requiring transcrip-
tion-dependent memory consolidation processes (1). Therefore, 
we examined short-term contextual fear memory in NR4ADN 
mice to test whether the Nr4a family of transcription factors 
contributes to learning or memory consolidation (Figure 2D). 
NR4ADN mice displayed levels of freezing in a 1-hour memory 
test that were similar to those of wild-type littermates (P = 0.71), 
demonstrating that NR4ADN mice are capable of learning the 
fear-conditioning task but have a reduced ability to retain the 
memory. Thus, it appears that Nr4a family function is involved in 
the consolidation of long-term contextual memory.
Memory deficit in NR4A mutant mice requires adult transgene expres-
sion. Regulation of the NR4ADN transgene by CaMKII-tTA led to 
transgene expression selectively in postnatal neurons (Figure 2), 
but it is possible that the defect in long-term memory observed in 
these mice is due to a developmental requirement for Nr4a family 
function or is a consequence of transgene insertion. To address 
these possibilities, we reared NR4ADN mice and wild-type mice in 
the absence of doxycycline, as before, and then placed the mice on 
a doxycycline diet from weaning until 2 months of age. A 1-month-
long treatment with doxycycline was sufficient to suppress 
transgene expression (Supplemental Figure 2E). After transgene 
suppression, 24-hour contextual fear memory performance in 
NR4ADN mice was equivalent to that in wild-type littermates that 
were also fed an identical doxycycline diet (P = 0.68, Figure 2E). 
These data are consistent with a requirement for Nr4a family func-
tion in the adult mouse brain, rather than a memory defect as a 
result of a developmental role of Nr4a family members or an effect 
caused by transgene insertion.
Intrahippocampal HDAC inhibitor treatment increases Nr4a gene 
expression. Memory enhancement by pharmacologically increas-
ing histone acetylation with HDAC inhibitors requires CREB-
mediated gene expression, and HDAC inhibitor treatment was 
observed to increase expression of only 2 out of 13 CREB target 
genes, Nr4a1 and Nr4a2 (13). This increase in Nr4a gene expres-
sion was accompanied by increased histone acetylation at the 
promoters of these genes (13). Additionally, intrahippocampal 
injection of siRNA targeting Nr4a2 attenuates the enhancement 
in memory observed with deletion of HDAC3 (22). These data 
suggest that Nr4a family gene expression may be an important 
Figure 3
The ability of an HDAC inhibitor to enhance memory is blocked by the Nr4a dominant-negative transgene. (A) Intrahippocampal injection of 
the HDAC inhibitor TSA (T) enhances acetylation of histone H3 (AcH3), as illustrated at 1 hour after TSA injection after training. Veh/V, vehicle. 
(B and C) Intrahippocampal TSA also increases expression of the (B) NR4A1 and (C) NR4A3 protein at the same time point. (D) Intrahippocam-
pal TSA increases mRNA levels for each of the 3 Nr4a genes at 1 hour after injection. (E) Injection of TSA into hippocampi after training enhances 
24-hour contextual fear memory of wild-type mice but fails to enhance memory of NR4ADN littermates. Error bars represent SEM. *P < 0.05. See 
also Supplemental Figure 3. Lanes were run on the same gel but were noncontiguous (white lines).
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component of the enhancement in memory by HDAC inhibi-
tors. We tested this hypothesis by examining whether the HDAC 
inhibitor trichostatin A (TSA) is capable of increasing memory 
in NR4ADN mice. Injection of the HDAC inhibitor TSA into the 
dorsal hippocampus caused increased acetylation of histone H3 
(Figure 3A). This increase in histone acetylation was accompa-
nied by a similar rise in the protein level for NR4A1 (Figure 3B) 
using a specific antibody against NR4A1. Furthermore, these 
changes at the protein level were accompanied by increased tran-
script levels for all 3 Nr4a genes (Figure 3D). Thus, our results 
agree with previous findings that HDAC inhibitor treatment 
enhances Nr4a gene expression (13).
Memory enhancement by HDAC inhibitors is blocked in NR4A 
mutant mice. The observation that Nr4a family members play a 
role in memory consolidation suggests that increased Nr4a gene 
expression after HDAC inhibitor treatment (Figure 3, B and C, 
and ref. 13) may contribute to memory enhancement produced 
by these drugs. Because NR4ADN mice retained some degree 
of long-term memory (Figure 2D), we were able to ask whether 
HDAC inhibitors are capable of enhancing memory in these 
mutant mice (Figure 3D). We injected the HDAC inhibitor TSA 
directly into the hippocampus immediately after contextual fear 
conditioning. Consistent with previous findings (13), intrahip-
pocampal TSA injection after training increased long-term con-
textual fear memory in wild-type littermates of NR4ADN mice 
(Figure 3E, P = 0.038). However, TSA did not enhance memory 
in NR4ADN mutant mice (P = 0.99). Thus, the function of Nr4a 
family transcription factors is required for memory enhance-
ment caused by HDAC inhibitors, suggesting that NR4A NRs 
contribute to this enhancement.
NR4ADN transgenic mice have reduced expression of NR4A target 
genes. To identify targets of NR4A signaling that could contribute 
to the memory deficit observed in NR4ADN mutant mice, we sur-
veyed gene expression using a high-throughput qPCR approach. A 
224-member gene panel was selected based on previous microarray 
studies after learning and neuronal activity. Using this approach, 
we identified 8 potential NR4A targets (Supplemental Figure 3) 
that we then pursued by low-throughput qPCR. We found 3 genes 
that were clearly impacted by NR4ADN expression (Figure 4A). 
Each of these genes (Bdnf, Fosl2, and Pak6) has potential NR4A-
binding sites in the proximal promoter region, and Bdnf has previ-
ously been identified as a direct target of NR4A2 (31). Thus, these 
genes may be part of the functionally relevant output of NR4A 
signaling during memory formation.
Because our pharmacological studies in NR4ADN mice sug-
gest that it is likely that TSA enhances memory by potentiating 
expression of NR4A target genes, we chose to further refine the 
list of potentially relevant targets of NR4A signaling in memory 
storage by examining potential NR4A target genes after TSA 
treatment (Figure 4B). TSA treatment increased expression of 4 
out of the 8 examined genes. Both Fosl2 and Bdnf were common 
targets of NR4A signaling and TSA treatment, suggesting that 
these genes might be downstream effectors for NR4A signaling 
that contribute to the function of NR4A signaling in memory 
formation (Figure 4C).
Discussion
In this work, we found that the NR gene expression increases 
in the hippocampus in the hours after learning a hippocam-
pus-dependent long-term memory task. Although these NRs 
span multiple subfamilies, all 3 of the NR4A orphan NRs show 
increased expression after fear conditioning. Our results are 
consistent with previous reports suggesting Nr4a1 and Nr4a2 
expression is induced by spatial and contextual exploration 
(19, 20). Furthermore, we found that blocking NR4A signaling 
in forebrain neurons, including in the hippocampus, selectively 
impairs long-term hippocampus-dependent contextual fear 
memory, without impacting short-term contextual fear memory 
or hippocampus-independent cued fear memory. These findings 
support previous suggestions that Nr4a function may contribute 
to memory formation. Further, we have confirmed that memory 
enhancement by HDAC inhibitors is accompanied by increased 
expression of Nr4a genes and found that blocking NR4A signal-
ing prevents the HDAC inhibitor TSA from improving long-term 
memory. Finally, we identified Fosl2 and Bdnf as candidate genes 
at the critical junction between NR4A signaling and HDAC inhib-
itors, as these genes have reduced expression when NR4A signal-
ing is blocked and increased expression when an HDAC inhibitor 
is infused into the hippocampus (Figure 5).
We found that 13 different NR genes have increased expres-
sion after contextual fear conditioning. These NRs can be broadly 
divided into the group: NR4A, TLX, ERR, LXR, PPAR, RAR, and 
RXR. As discussed earlier, previous studies provided the sugges-
tion that the NR4A group may contribute to memory storage 
(5–11), and we have provided compelling evidence supporting this 
possibility in this article. Yet, there is also evidence that the other 
NR groups identified in this study may also contribute to memo-
ry storage. For instance, TLX regulates the proliferation of adult 
neural stem cells, and conditional knockout of Tlx in the adult 
brain causes a defect in neurogenesis and spatial memory (32). 
Figure 4
Common gene targets are impaired by NR4ADN expression and 
increased by TSA treatment. (A) NR4ADN transgenic mice have 
reduced expression of several putative Nr4a target genes, including 
Bdnf, Fosl2, and Pak6. (B) Intrahippocampal TSA treatment increases 
expression of several genes, including Fosl2 and Bdnf. Error bars rep-
resent SEM. *P < 0.05. See also Supplemental Figure 4.
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Perhaps surprisingly, contextual fear memory was not impacted 
by Tlx deletion. ERRα and ERRβ both show increased expression 
after fear conditioning. Because ERRs bind to many of the same 
targets as the ER and estrogen signaling contributes to memory 
formation (6, 9), the relationship between this increase in ERR 
expression and estrogen signaling may be an interesting area of 
future study. Alternatively, the role played by ERRs in mitochon-
drial function and energy metabolism (33) may suggest that these 
processes contribute to learning and memory as has been sug-
gested elsewhere (34). LXR (35) and PPAR agonists (36) have been 
reported to improve learning and memory deficits in Alzheimer 
disease mouse models, suggesting that defects in signaling for 
these 2 classes of NRs may contribute to pathological memory 
deficits. RXR and RAR both respond to retinoid acid signaling, 
which has been previously linked to learning and memory. Deple-
tion of vitamin A, the dietary source of retinoids, leads to defects 
in synaptic plasticity (37) and hippocampus-dependent memory 
(8) that are acutely reversible by supplementing retinoids. Addi-
tionally, knockout mice for RARβ and RXRγ show abnormalities 
in hippocampus-dependent memory and synaptic plasticity (10). 
Therefore, it is possible that the changes in RXR and RAR expres-
sion observed in this study could contribute to memory by altering 
retinoid sensitivity after learning.
Increased expression of Nr4a genes after learning is consis-
tent with these genes being important activity-dependent tar-
gets of CREB (24), a transcription factor involved in long-term 
memory formation (38). Additionally, memory enhancement 
by HDAC inhibitors requires the interaction between CREB 
and the histone acetyltransferase (HAT) CREB-binding protein 
(CBP) as well as being accompanied by increased gene expres-
sion for Nr4a1 and Nr4a2 (13). In other systems, NR4A signaling 
is mediated by redundant roles of these 3 transcription factors 
(see ref. 39 for review). For these reasons, we undertook an analy-
sis of NR4A function in memory formation using a well-tested 
dominant-negative strategy that was developed for the study of 
NR4A function in other physiological contexts (25, 27). Using 
this approach, we found that impeding NR4A function impairs 
long-term memory formation. We have now found that imped-
ing NR4A signaling blocks the ability to enhance memory by 
HDAC inhibitors, suggesting that this family of NRs may be a 
useful target for modulating memory function.
Previous studies have found that Nr4a1 gene expression increases 
in hippocampal area CA1 after contextual fear conditioning (19). 
Additionally, Nr4a2 gene expression increases within both CA1 
and CA3 after spatial exploration (20). In this study, transgenic 
NR4A dominant-negative protein was expressed under control of 
the CaMKII promoter, limiting expression to forebrain excitatory 
neurons, including those in the hippocampus. Behavioral deficit 
in this transgenic mouse line supports a role for NR4A signaling 
in hippocampal memory consolidation. Transgene expression 
in this mouse line was fortuitously restricted to neurons within 
hippocampal area CA1 and the dentate gyrus. The HDAC inhibi-
tor injection protocol used in this study targets hippocampal area 
CA1 (13, 40, 41). Together, our data suggest that NR4A proteins 
act within excitatory pyramidal neurons in area CA1 to support 
memory consolidation and the enhancement in memory achieved 
with HDAC inhibitor treatment.
An important future direction is the identification of the 
mechanism by which NR4A signaling supports memory forma-
tion, which is likely to be through the activation of downstream 
target genes. We found that mice expressing the NR4ADN 
transgene have impaired expression of genes Pak6, Fosl2, and 
Bdnf. Both Fosl2 and Bdnf are also potentiated by HDAC inhibi-
tor treatment. Fosl2, also known as Fra2, is a member of the 
AP-1 family of transcription factors, a family that is known to 
be important for memory storage (42). FOSL2 is a long-lasting 
FOS-related antigen that, like ΔFosB, can be retained long after 
induction (43), suggesting that the persistence of this protein 
during memory storage may be an interesting subject of future 
inquiry. Bdnf is a known Nr4a target gene (31) that contributes 
to memory formation (44). The specific Bdnf promoter 1 that is 
impaired in NR4ADN mice is activated in a second, late response 
to neuronal stimulation (45). Thus, regulation of this promoter 
by NR4A signaling may represent an important mechanism gov-
erning Bdnf expression in later waves of transcription after learn-
ing, an intriguing idea in light of the growing appreciation that 
Bdnf contributes to memory at late time points after learning 
(44). The impact of the NR4ADN transgene on Bdnf expression 
provides a direct link between NR4A signaling and an effector 
gene known to be involved in memory formation (44). Addition-
ally, Bdnf expression is potentiated by TSA treatment, suggesting 
that this gene might contribute to the enhancement in memory 
observed with TSA administration.
Figure 5
NR4A signaling contributes to memory formation and enhancement by 
HDAC inhibitors. HDAC inhibitors increase Nr4a gene expression, and 
blocking NR4A signaling prevents memory enhancement by HDAC 
inhibitors, suggesting a model in which NR4A target genes contribute 
to memory enhancement by HDAC inhibition. In this figure, arrows rep-
resent processes that stimulate gene expression and enhance memory 
formation. In contrast, blunt ends signify pathways that repress gene 
expression and limit memory formation. Nucleosomes are indicated 
by the green barrels that are encircled by the gray ribbon, which illus-
trates promoter DNA. Acetylation (ac) of the histone proteins that 
constitute the nucleosome (N) is dictated by a dynamic equilibrium 
between HDAC and HAT activity. Impairing HAT activity would be pre-
dicted to reduce Nr4a gene expression and impair memory formation. 
As illustrated in this study, blocking HDAC activity increases Nr4a gene 
expression and enhances memory formation. Also, inhibiting the func-
tion of NR4A proteins using a dominant-negative protein blocks memo-
ry enhancement by HDAC inhibition and impedes expression of several 
putative NR4A target genes. The increase in Nr4a gene expression 
observed after TSA injection after training is accompanied by increased 
expression of the putative NR4A target genes, Bdnf and Fosl2, two 
memory-associated genes that may contribute to the molecular mech-
anism of memory enhancement by HDAC inhibitors.
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The present findings are especially exciting because Nr4a poly-
morphisms have been identified in patients with schizophrenia 
(46), and Nr4a gene expression is reduced in patients with schizo-
phrenia (47). Thus, impaired Nr4a function may contribute to 
the cognitive impairments that accompany this psychiatric disor-
der. Agonists for other NRs, such as PPAR and LXR, have shown 
promise for the treatment of Alzheimer disease (48). Over the last 
several years, small molecules that increase the activity of one or 
more NR4A proteins have been identified (49, 50). Our data sug-
gest that the therapeutic value of these NR4A agonists is worthy 
of further investigation. Future approaches to ameliorate the cog-
nitive impairment associated with neuropsychiatric disorders will 
greatly benefit from the knowledge that Nr4a family function is 
required for memory enhancement by HDAC inhibitors. The spe-
cific requirement for Nr4a family function in memory enhance-
ment by HDAC inhibitors promises to provide more refined tar-
gets for memory improvement than would be possible with even 
the most specific HDAC inhibitors.
Methods
Subjects. Mice were maintained under standard conditions, with food and 
water available ad libitum. Adult mice (2 to 6 months of age) were kept on 
a 12-hour-light/12-hour-dark cycle, with lights on at 7 AM. All behavioral 
and biochemical experiments were performed during the light cycle, with 
training and testing at approximately 10 AM.
The HA-tagged truncated Nr4a1 plasmid (27) (obtained from Jacques 
J. Tremblay, CRCHUQ, Quebec City, Quebec, Canada) was subcloned 
in-frame with the YFP tag in the pcDNA6.2 N-YFP-GW TOPO vec-
tor (Invitrogen, no. 45-1903). The YFP-HA-NR4ADN fragment was 
ligated into the EcoRV site of MM400 to place the YFP-NR4ADN into 
a hybrid intron structure under control of the tetO (30). MM400-YFP-
HA-NR4ADN was purified by CsCl gradient centrifugation. The 2.7-kb 
tetO-YFP-HA-NR4ADN transgene fragment was injected into pronuclei 
of C57BL/6 zygotes (Transgenic and Chimeric Mouse Facility at the Uni-
versity of Pennsylvania). Founders were crossed to C57BL/6J mice bear-
ing the CaMKII-tTA (line B) transgene (30). Genotyping was performed by 
Southern blotting using transgene-specific probes and/or PCR.
Behavior. Fear conditioning was performed as previously described (13), 
with handling for 3 days prior to conditioning. Briefly, the conditioning 
protocol entailed a single 2-second, 1.5-mA foot shock, terminating at 
2.5 minutes after placement of the mouse in the chamber. Testing was 
performed at 1 hour or 24 hours after training over a 5-minute interval. 
For experiments involving TSA injection, 0.75-mA shock intensity was 
used to avoid a ceiling effect. Cued fear conditioning was performed as 
described for contextual fear conditioning, except that a 30-second cue 
(white noise) co-terminated with a 0.75-mA foot shock. For cued testing, 
mice were placed into a new context (a distinct conditioning chamber 
with smooth flat flooring, altered chamber dimensions, and a different 
odorant) for 2-minutes in the absence of the conditioned stimulus (white 
noise), followed by a 3-minute presentation of the auditory conditioned 
stimulus. Conditioning was quantified by measuring freezing behavior, 
the absence of nonrespiratory movement (14), using automated scoring 
software (Clever Systems).
Intrahippocampal TSA injection. Based on previous work (13, 40, 41), 
bilateral 22-gauge guide cannula were implanted 1 week prior to train-
ing at the following coordinates: anteroposterior, –1.7 mm; medio-
lateral, ± 1.5 mm; 1.5 mm dorsoventral. Injection cannula extended 
0.7 mm below the guide cannula. TSA (16.5 mM, AG Scientific) or 
vehicle (50% ethanol) was injected at a rate of 0.5 μl/min for 1 minute 
immediately after training.
RNA preparation. Hippocampal dissections were performed on ice after 
conditioning alternating between control and experimental groups. 
RNA was prepared using a modified TRIzol RNA extraction, followed by 
RNeasy (Qiagen) purification and DNA-free (Ambion) DNase treatment. 
RNA concentration was ascertained using a NanoDrop spectrophotometer 
(ThermoFisher Scientific).
cDNA synthesis. Real-time PCR template cDNA was produced using the 
RETROscript Kit (Ambion). For each reaction, 1 μg total RNA was added 
to a 20 μl total reaction volume composed of 50 mM Tris-HCl (pH 8.3), 
75 mM KCl, 3 mM MgCl2, 5 mM dithiothreitol, 500 μM each dNTP, 
5 μM random decamer, 10 units RNase inhibitor, and 100 units MMLV-
RT. Control reactions were performed lacking template or reverse tran-
scriptase. Reactions were performed at 44°C for 1 hour, followed by heat 
inactivation at 100°C for 10 minutes. Reactions were diluted to 2 ng/μl 
in water to 500 μl final volume.
Real-time RT-PCR. High-throughput qPCR was performed as described 
previously (17). Briefly, 10 ng cDNA was assayed using multiplexed Taq-
Man qPCR probes. Data were normalized to 18S rRNA, and t tests were 
performed against the appropriate circadian control group. Subsequent, 
low-throughput qPCR was performed on the ABI7500 Fast or Viia7 Real-
Time PCR system using 3 separate housekeeper genes for normalization 
(Gapdh, Tuba4a, and Hprt). Relative quantification of gene expression was 
based on the ABI users’ bulletin using a ΔΔCt method and described previ-
ously (13). Fold difference in mean value for biological replicates is pre-
sented, and all samples are distinct biological replicates.
Immunolabeling. For immunolabeling experiments, mice were transcar-
dially perfused with 4% PFA, and 30-μM coronal cryostat sections were 
prepared. Sections were permeabilized in 0.1% Triton X-100 and then 
incubated in 1% H2O2 in PBS for 15 minutes at room temperature. Sec-
tions were given 3 washes for 5 minutes each before being blocked in PBS 
with 5% preimmune serum and 0.3% Triton X-100 for 50 minutes at room 
temperature. Sections were triple washed for 5 minutes each in PBS and 
then incubated overnight at 4°C in PBS with 2% preimmune serum (same 
species as that of secondary antibody; Jackson ImmunoResearch Inc.), 
0.3% Triton X-100, and primary antibody (anti-GFP, 1:1,000, Invitrogen 
no. A11122; anti-HA, 1:1,000, Roche clone 3F10). Sections were triple 
washed for 5 minutes each in PBS, followed by incubation in biotinyl-
ated secondary antibody for 2 hours at room temperature in PBS. For HA 
immunohistochemistry, biotinylated goat anti-rat antibody (1:1,000, Jack-
son ImmunoResearch Inc.) was used as secondary antibody, and biotinyl-
ated donkey anti-rabbit antibody (1:1,000, Jackson ImmunoResearch Inc.) 
was used for the remaining labeling. Three 5-minute washes in PBS were 
followed with incubation for 1.5 hours at room temperature in Vectastain 
ABC solution (Vector Laboratories). Sections were again triple washed 
in PBS, incubated for 10 to 15 minutes in 0.2 mg/ml 3,3′-diaminobenzi-
dine in PBS, and then triple washed in PBS with sodium azide (0.01%). 
Stained sections were mounted onto glass microscope slides in 0.7% gela-
tin. Sections were examined and digitally photographed through a light 
microscope. For immunofluorescence, Alexa Fluor 488–coupled chicken 
anti-rabbit IgG (1:5,000; Invitrogen) was used as secondary antibody. After 
incubation in fluorescent antibody, sections were washed 3 times in PBS 
for 5 minutes each and then mounted on to glass slides in 50% glycerol/
PBS containing 20 μg/ml propidium iodide. Images were captured using a 
Leica (Wetzlar) TCS SP2 confocal microscope.
Coimmunoprecipitation. Mice were cervically dislocated 30 minutes after 
placement in a novel context. Hippocampi were dissected and flash frozen 
on dry ice. Hippocampi were homogenized in 1 ml of hypotonic lysis buf-
fer (10 mM HEPES [pH 7.9], 1.5 mM MgCl2, 10 mM KCl, 1 mM EDTA, 
plus protease and phosphatase inhibitors [Sigma-Aldrich]), followed 
by rocking at 4°C for 30 minutes, and then centrifugation at 1,000 × g 
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low-up real-time qPCR data were analyzed with ANOVAs to detect overall 
effects of training and nonparametric Kruskal-Wallis ANOVAs for planned 
comparisons to home cage controls. High-throughput qPCR data to detect 
NR4ADN target genes was performed using ANOVAs with training and 
genotype as factors. For all statistical tests, P < 0.05 was considered signifi-
cant. Experimenters were blind to genotype, and genotypes were confirmed 
after experiments were completed.
Study approval. All animal care and experiments were consistent with NIH 
guidelines and approved by the Institutional Care and Use Committee at 
the University of Pennsylvania.
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for 15 minutes at 4°C to pellet nuclei. Nuclear pellets were resuspended 
in 300 μl E1A lysis buffer (250 mM NaCl, 0.1% Nonidet P-40, 50 mM 
HEPES [pH 7.0], 5 mM EDTA, plus protease and phosphatase inhibitors 
[Sigma-Aldrich]) and gently rocked at 4°C for 30 minutes. Nuclear lysates 
were centrifuged at 1,000 × g for 15 minutes and 4°C to pellet nuclear 
debris. Supernatants were diluted to 1 ml in E1A lysis buffer containing 
1 μg biotinylated anti-GFP (Invitrogen) and gently rocked overnight at 
4°C. For immunoprecipitation, 50 μl of Pierce streptavidin magnetic 
beads (Thermo) were then added to the protein solution on the following 
day. Beads were washed 3 times in E1A buffer, and antigens were eluted in 
30 μl of 0.1 M glycine (pH 2.5).
Western blotting. NuPage SDS loading buffer and 2-mercaptoethanol 
(Invitrogen) were added to samples prior to a 10-minute incubation at 
100°C. Proteins were resolved by polyacrylamide electrophoresis on a 
NuPage Bis-Tris gels (Invitrogen) and transferred to a PVDF membrane 
(Invitrogen) for Western blotting. Blocking was performed with 5% milk. 
Washes and primary antibody incubations were performed in either 
TBS-0.1% Tween-20 (anti-AcH3k9/14, 1:5,000, Millipore 06-599; anti-
H3, 1:5,000, Abcam ab1791; anti–β-tubulin, 1:20,000, Sigma-Aldrich 
T4026; anti-NR4A1, 1:1,000, eBiosciences 14-5965; anti-Nr4a3, 1:1,000, 
Abcam ab41918) or PBS-0.1% Tween-20 (anti-NR4A2, 1:2,000, Santa 
Cruz Biotechnology Inc. SC991). Three 5-minute washes were followed 
by incubation in PBST with HRP-conjugated goat anti-rabbit second-
ary antibody (1:1000, Santa Cruz Biotechnology Inc.). The blot was 
washed 3 times in PBST for 5 minutes each and treated with ECL West-
ern Blotting Detection Reagent (GE Healthcare) for chemiluminescence 
detection. Membranes were then exposed to film for 1 to 10 minutes 
and developed for analysis.
Statistics. Data are expressed as mean ± SEM. For behavioral experiments, 
ANOVAs were performed, followed by Student-Newman-Keuls post-hoc 
tests. Gene expression survey of NRs was analyzed with 2-tailed t tests. Fol-
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